Philip Morris
Warner - Lambert / Parke - Davis Award Lecture Viral Pathogenesis of Atherosclerosis Impact of Molecular Mimicry and Viral Genes Vol. 139
Fields
- Author
- Hajjar, D.P.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- ELLIS,CATHY/OFFICE
- Named Organization
- American Journal of Pathology
- Parke Davis
- Warner Lambert
- Parke Davis
- Site
- R461
- Named Person
- Altieri, D.
- Baird, A.
- Basilico, C.
- Benditt
- Edgington, T.
- Etingin, O.
- Fabricant
- Fabricant, C.
- Fabricant, J.
- Falcone, D.
- Florkiewicz, R.
- Friedman, H.
- Gimbrone, M.
- Kaner, R.
- Mansukhani, A.
- Marcus, A.
- Mccalfrey, T.
- Minick, C.R.
- Nachman, R.
- Nicholson, A.
- Pomerantz, K.
- Ross, R.
- Silverstein, R.
- Smith, S.
- Baird, A.
- Request
- Stmn/R1-143
- Author (Organization)
- American Assn of Pathologists
- American Journal of Pathology
- Cornell Univ Medical College
- American Journal of Pathology
- Litigation
- Stmn/Produced
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- mdq07e00
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Ae+sPum Jo4rrul of Pmholoo. VbL 239, rb. 6s Datismt+n 1991
Cxg,.O.o."W%= An=WzWn CfPA6Dk8=
WARNER-LAMBERT/PARKE-DAVIS
AWARD LECTURE
Viral Pathogenesis of Atherosclerosis
Impact of Molecular Mimicry and Viral Genes
David P. kajjar
Prorrt dtt DE.pm-nea of BiocbernEspy and ParbohV,
CrvxeH lfrriuastty Medtral Calkge, Nau York, New Yai
Xurnan atibervgenaYs Lr a plafotsopic process uritb an
wrdeflned catr.se. Several pathologic factors bave
been lixkeid to tbe dLuase procesr, including asterial
injury or activation of tbe endotbeliu"4 uticb may
initiate proatberosclerotic eventa !ac Oe uessel u41L
Atbeiosclerotic lesiosss aee rbaracterized in parS by
tbe pracenoe of activated immune ul4 abnormal
cell prollferardost, and alttreid cholesterpl metabo
ilsrn Tbese activated lmmunocompetent cells in
Plaques produce vasoactive m.diators tbat can alter
bomaostasic and maypromote the artsrlopotb}: Botb
molecttlarand structtssrrl evidence irpserented thas
berpesvirreses, by uaay of inductron of altened gene
function and cellular cboGxterol metaboline, aou-
pled wit#+ tbeir ability to activate coagulation and a
monocyte r+eceptor on tbe infected eridotliellum, are
inuolued in ma}orpatbogenic events assocYarrd rvr;tb
atiKrosclerotis and d"rombaele Work from the au-
tbor't taboratory, as unell as from otber researcb
group; bavv sboum t6at avzan and buff&= bespetvi-
rusas act rpectifiaally to induce alterations to the sur
,Jizce and inner layers of the blood ueael u+a11 tfiat
rnay pradispose to atbesarclerosis and its attendent
dtnioal compii=tioss (AmJPadoi 1991. 13,9:1195-
1211)
An important fsnure of the penesis of human atheroscle-
rosis is its muttifacmrial nature. No single errtity has been
tinked diroctty to its pathloQenesis in.,tMr animal models
of tho disease or in the human art.riopaihy. Eviderlce is
accurnulatirp that eady deveioprrwtW changes in spe-
c'iflc vascular beds highly susceptlble to the disease are
paramount to the laiter alterations of arterial metabolism
that predisposes to subsequent atheromatous
chanpas.'-'3 Utxloubtedly these changes are amplified
by risk factors such as tlypercttiolesterolemia, hypenelr
sion, smoiat~, and diabetes.
For almost 20 years, interest in a viral cause of ath-
erosderosis has continued, spurred by the oariy worlc of
Bersditt and Bendrtf and Fabricant et a1.5° This perse-
verance to define the vi4 cytopatfloJoyic mechanisms
in4oived has certainly been enhanced by studies of an
tulimal model ot viraily induced atherosclerosis under
normocholesterolemic conditions,°"° and by the recog-
nition of the association of this disease in patients who
have underQore cardiac traalsplant surgery, butwho elso
are infected with cyrprregalovirus,'a,' one of the seven
herpesvin~ses now known to infect humans.12
Vascular injury purported to be invofved in early
stages of the arteriopathy is also a corrrnon feature of
acuta herpesvirus infection. Recent studies have identi-
fied herpesvirus antigens and nucleic acids in the vas-
cuiar vwaji"-'° after their passage through the endothe-
lium. At the biochemical level, a variety of herpesvirus-
induced paiflobiobgic changes have been documented
within va,scular cells that impact on cellular lipid (choles-
terol)° and connective tissue (proteoqlycans) metabo-
lism.'° In fact, ttse harpesvirus-induced atteratiorls in lipid
metabdism in vifro and in vivo paralW those patholcgic
events rtininiscent of the artetiopatty found in the human
disoase,cso4-2
Fi.rpecvinises induce an arterial lesion characteristic
of leukocytodastic vasculibs. There is granuloeyte infiltra-
tion in the artery, accompanied by ttuombin formadon
AOCEQeO lor OubiQGm Au]ttQ ®.1491.
AEeta=rsprirt r.4mrslo Dr. DariG P. M.pr. Prof®ordBbCtfar).
iftry and P&p1?gy, COrT1d Unir.r.¢y MedP1! CObepe, 1300 YUk Aw-
rue, nlea YoaK NY 10321.
1195
I

1196 HaiJar
.SlpDet.nnbe+ 1.992. Vol. 139. No, 6
and fibrin deposition.2` Hence this veciar has the ability
to influence not only atherosclerotic chatlges but also
processes related to a thrombotic diathesis. Because the
virus causes a fattyy-proliferative lesion in animals that oo-
casionaly contains microthrombin,'such events support
the hypothesis that surfaca expression of adhesion mof-
ecules and intimal hyperpiasia may be initiated by a vi-
relly induced event. This may trigQer cell proliferation by
enhancement of growth factor or by cyrolune release
from vascular cells or adherent macrophages, Or it alro
may alter the balance between mitogen and growttt sup-
pressor synthesis in the vascular well.
Based on this background informaGon, both molecu-
lar and structural evidence are highlighted to support the
hypothesis that herpesviruses, by akering gene function
and cellutar lipid metabolisrn, coupled with the abiliry to
activate the coa8ulation system and a morxx,yte recep-
tor on the endothefium, are invoived in pathogenic events
associated with human atherosclerosis. Information
about candidate virat or transforming genes potentialiy
related to atherogenests a(so are presented.
Epidemiologic Evidence Linking
Herpesvirus and Atherosclerosis
Herpesvirus infections are widespread in the general
populatioon.2r-a' They are ubiquitous viruses found in
most tissues of the body, even in blood ceils, By 10 years
of age, more that15096 of children dertnnstrate antibod-
ies to herpes simplex virus (H" type 1.25 The incidence
of herpes simplex vinus, type 2. is more difficult to esti-
mate, but two studies cite a prevalence of up to
In the 35- to 44year-0id age group, substantially more
than 1 t?96 demonstrate arrbbodies to HSV type 2,26-2' A
more recent study demonstraied that the incidence of
infection approaches 209'o in the population aged 15 to
74 years.27 It has now been documented that seven drf-
ferent herpesvirus can infect hurnans.'2
Human atherosclerosis is not completeiy accounted
for byall krown risk factors. Th;s suggests that tfle human
risk factors may by synergistic with other, as of yet un-
identi8ed, initiating factors.'26 A direct seroepidernio-
logic link between cytomegalovirus (CMV) infection and
atherosclerosis has been suggosted.2° A cas¢.cantrof
study was perforrrled wherein patients who underwent
rardiovascular surQery were compared with a control
group of subjects wittt similar cholesterol levels and epi-
demiolog ic factors but who were not undergoing surgery.
In approximatefy 160 pairs of patients, the prevalence of
CMV antibodies was higher in the surgical group than in
the control group (90% and 74%, respectively), and a
greater percentage of surgical cases than controls had
high trters of CMV antibodies (57% and 26%, respec-
tively), There was no correlation between arrtibody titers
and blood levels of cholesteroi or triplycerides. Interest
ingly a recent Fremingham Heart Study failed to find an
overall a5sociation between fevef blisters or cold sores,
with a 6-year incidence of caronary heart disease in pa-
tients 58 to 89 years of age.30 Previous work in this group
of patienis had shown a strong correlation of a self-
reported history with serologic evidence of previous
herpes simplex virus type 1(I-iSV-1) infection. This study
does not completely rule out tfze possibility of a relation-
ship between HSV and atheroscierosis, particularty be-
cause a subgroup ot women with recurrent cold sores
had twice the risk of developing coronary heart disease.
The strongest epidemiologic link between infection
with herpesvin~ses and atherosclerosis in humans is in
the heart transplant population. Several recent studies
have demonstrated a strong correlation between CMV
infecdon and accelerated atherosclerosis,'0" At Stan-
ford University, 300 cardiac transplant pat;ents were
treazed with immunosuppressan and were f0liowtd pro-
spectrvely for the occurrence of CMV infection and the
derelopment of atherosclerosis. Of those tested. 91 pa-
tiets developed CMV infections, based on: 1) positive
cultures for CMV. 2) demonstration of daacteristic CMV
inclusion bodies in tissue samples, or 3) a fourfold rise in
garrrra 3 imru.unoglobuiin (19G) CMV antibodies. After a
5-year folbvwup, the rate of graft bss due to acceserated
aiherosderosis was 69% in CMV-infected patients, but
only 37% in the non-CMV-infected group.10 Furthermore
there was a 1t}fold greater incidence of patients who
died with mare than 50% luminal obstruction of their cor-
onary arteries. These individuals had CMV infections./0
Similar results wers reported from a sorne..what smaller
study at the University of Minnesota." Thts study corn-
pared rates of CMV infectiort and atherosclerosis in 102
immunosupprG;sed paisents who had received a car-
diac transplant and survived for at least 1 year, At 2 years
after transplant, 32% of the CMV-positive patients had
corLxmiry artery disease, as opposed to 10°,6 of the CMV-
negative patients. To date, these findings provide the
strongest evidence in humans linking herpesvirus infeo-
tion with atherosclerosis.
Pathologic Evidence Linking Herpesviruses
with Atherosclerosis
After the publication in 1973 of a landmark study by Dr.
Eari R Benditt on the possible rnonocknal nature of atf'~-
erosclerotic Iesions.' his laboratory was one of the first
groups to docvment the presence of herpesvirus nudeic
acids in arterfal tissue removed during coronary bypass
surgery. They used in sitU hybridizaibrt techniques."
Approxirnaiel'y 10% of 160 tissue samples were positive
in
wit
lea
iiy ~
turt
var
I
I
I
ticle
da
I
Ing ~
sho
I
.
DNI
d em
g. Cn
diaiE
c0uL
Sug~
ataa
senc
mew
Perh
trof c
thick
F
forrtx
cal e
VlCfin
acid
L-4
I
I
I
I
I
I

Yra! Pathog.nesit of Ath.nosclerosis 1197
47 ORnels 1992, vcl 1,39, Na 6
I
I
I
I
r
I
a
M
I
I
I
1
F
for herpeslirus. A second series of experiments exam-
ined tissues that contained abnormally thickened intima
Ffty percent of the samples reacted positively with an
HSV2 prabe. Postive staining occurred in cells bcated
in discrete fod, characterized by increased cxllularity
within or adjacent to the intima Melnick and his cot-
lea9ues"'s'6 e)dended these studies, focusing primar-
ily on CMV, which they were able to detect in cells cul-
tured from arterial tissue derived from patiertis with ad-
vanced (grade III) aiheroarteriosclerosis.
In 1984, Gyorkey et al" reported the detection of vi-
rians of the herpesvirus family in e(ec=m microscopic
sections from aortae of 10 of 60 patients with atheroscie-
rosis undergang cardiovascular surgery. These viral par-
ticles in various stages of replication included empty nu-
cleocapsids and virions with dense cores. They were
present in smooth muscle and erxiothdial cells. Of 1360
grids that were examined, 35 show.d evidence of viral
presence. Petrie et al,'s using in situ hybrid'¢aaion tech-
niques, dernonstraied increased detection of CMV in cu4-
tuned smooth muscle cells from arterial plaques by stain-
ing for viral antigens, Most recentty, Hendridcs et al"
showed that detection of CMV nuGeic acids by the poly-
merase chain reaetien (PCR) was possible in 90% of
samples obtained from patients with severe atheroscle-
rosis as compared with only 50% in patients with minimal
or no atherosclerosis. The presence of the complete viral
genome was shown in these samples by botti dot blot
DNA hybridization and PCR, using probes and primers
derived from the immediate early and late genomic re-
gions of CMV. Messenger RNA trarscribed from imme-
diate-eariy CMV genes but not the late genomic regions
could be demonstrated by in sltrj DNA hybridzation. This
suggested that CMV exists in the vessel wall primarity in
alatent state, wh.re ezpression of immediate-eary mes-
senger RNA transcripts may occur withnn expression of
messenger RNA coding for sttuctural capsid proteins."
Perhaps this may lead to an alteration in factors that cor-
trol growth in the vessel wall, predisposing to infimal
thickening.
Rnally, Yamashiroya and his colleagues' have per-
formed both DNA hybrid'ization and immunohistochemk
cal experiments on coronary vessels of young trauma
victims to identify evidence of viral antigens or nucleic
acid sequences at earlier stages of ttw art.riopattry, Ev-
idence for HSV or CMV was detected in 8 of 20 speci-
mens from coronary arteries. The viral DNA or ant;pens
were found 'n celis of the irrtact luminal surface as well as
in Jocal clusters of spindle-shaped or foam cells in the
irtmal layer. Taken tngeti'w, this study and those rnen-
tioned above support the hypodiesis that thase herpes-
viruses may conm'bute to early events in ath.rogenesis,
because the herp.svirus can be found in the vasculature
at various stages of tr,e arteriopatrry.
C3eariy herpesvin~ses can iMeci arterial calis. In faet.
HSV types 1 and 2 can infect both bovine and human
vascular endothelial cells" `2 and vascular smooth mus-
de cells.a Similarly hurnan CMV also can infect such
cells.33" Infection of cells in vrbo with HSV resuhs in an
inhibition of host cellular protein synthesis. This is de-
picted in Figure 1. This 'shutoff' of host cell protein syn-
thesis occurs in two stops. The first stage, occurring in
the first few hours after infection. 'early shut4ff,' is medi-
ated by a virion-associated protein and causes dissoG-
ation of host celi mRfVAs from pofysomes. rendering the
mRNA nonfunctional and enhancing mRNA degrada-
tion.35m Kefalides and ZZaie" have demorutrated tttat
this mechanism is relevant to the mRNAs encoding ex-
tnscellular matrbc proteins in both human endothelial cells
and human arterial smoottt muscle cells's infxted with
HSV-1 fn vitfo. The delayed shut-off of host cell protein
synthesis is thought to be mediated by a newly synthe-
sized immediate eariy-viral gene product that subse-
quently causes degradation of cellular messenger
RNAs.9 Some of the viral genes responsible for the in-
hibition of host cell protein synthesis have been mapped
and are discussed elsewhere.'O
8iochemistry of Viral-induced
Atherogenesis
The concept that herpesviruses play a ma}or roie in the
cause and pathogenesis of atherosderosis is supported
by two observations:1) The findings of Paterson and Cot-
tral, reported in 19b0.41 in wtuch res,rolymphomatosis
and coronary scierosis induced by an infectious agent
was linked to arteriosclerosis in chickens; and 2) intrecel-
luiar and extracellular cholesterol accumulation was ob-
served in cell cunures infected with feline herpesvfrus.s
The work from this laboratory and those of our collab-
ora¢ors have shown that atherosclerosis in chickens in-
duced by an avian herpesvirus infection can provide
con.siderable experimental evidence to support the car
aept that herpesvfn1 ses are irnrolved in the pathogenesis
of atherosclerosis." Pathogen-free normocholoster-
olemic chickens were infected with 100 plaque-fomvnp
units of an avian herpesvirus that causas Marek's dis-
ease (MDV). Uninfecied pathogen-free chickens senved
as a confrot. Mareks disease virus (MDV) is a herpesvi-
rus that causes malignant lymphomas of T-cell origin in
this animal moda!z Primarily nerve lesions and visceral
tumors develop. An antigericafiy related herpesvirus to
MDV, herpesvirus of turkeys (I-M'), has been used suo
cessfully by the poultry industry as an effective vaccine
against the neaplastic effects of MDV.`z Nonpathogenic
for turkeys and chsckens, tttis naturaly oxurring herpes-

1198 Ha}lar
VP Dea.+rtbe* 1991, Vo(. 1'J9, Na 6
I. Competition
II. Dissociation nwinnlr tlt. Degradation
I
I
Nost mRNA
Namit trartslatian
I
I
Djnooiatton of host a!l mRNA Irom poysomes
Fgues 1. 1'flpadsttlCal seprnu of rfwpzbokgfc dotv+ga rlrs>ftg uadfj~trtdt~xf asbEesdooSG~ 7bir
srix+na desai6es dner srsps dw can
l,ead m deviardproraie ry>v/xds in a'r manmaliart tell onat ClAafies'tgat uirb 6erpes v&uc PSm
c'antpeaanas ocrras ubtra tha tsal n[RNit
rut "eonyxte"aids ds6msndiNw in rfxearai nsRNApcnl in riie e.lldrav~ the rfmo~laeion.p~acrts
yLt'srnesalhumr ojt~r'al btfcu1on wal
mRNAS cros 6r dx p.edomistrW RNA e c4sQ{os t&a vr isantlrIIrd in rbe rnfrasd c.l; podua,g cswl
P.ords+t !n addLrlon, dmwhaon of
dw aas cetl mR1vAfm m mrpoly.+ernes em+ oms vt dx inf.ewd crllr. 3venupr>;,Q dse ne.mat aa,urarion
of dw RN:, t+mcsaiprI fi,eat .br 33'
dbw.Ytos on obupolyaome. WC rs dx ncaiarfnF codorr in eurQyvic celis jar vaulanon}. FbuUty,
dagradarion of dw R1VA owuozpb b,v a
va[o.i-+rlaand o. nswlv syredis-ed uirally rnaMtd f=tofs) (ddpiacd by -bw o+rsce>'tt moon fig:s)
cat areoo 0169 baa a!{ prsdig,a"
m dev.asuxi RNA rrisitstaao.: and b- poms'n rvndAset 7ba.O.r4ff ofP~owk OwuhesLc leads to aknurio.u
bt a.rpta/Lelar maois and
d.-4W+dprodr..arlo+t ef dcte eLMnW dw asr b¢oked ns ltptd aatabolrc acrativ. T!r cysopoaho/osio
cl/eca indu& cyrtp4,wnlc lPid
aaonulanort and aherariMec !n a'x eza+rwiluGb mrcri= Rep-trtmd rei& pembs,io.t"
virus eliciLs an imrrtune response in chickens that prtt
teCts aqainst subsequent tumor devetopment by MDY.`Z
A mtsst interesting property of MDV is that it can cause
atherosclerosis reproducibly in specific-pattlogen-free
chickels"; and that imrnunizatlon of chickens with F VT
can prevent MDV-indutxd atherosejerosis.a-' In tact, the
distributionai, morphologic, and biochemical nature of
the athernsclerotic lesions induced by MDV infection
ciosely resembled human atherosclerosis' Coronary ar-
tEries, the aorta, and its branches were affected, resulting
in fatty or fatty-prvliferetivve-type lesions.'
We showed that aortic tissue from the tlorrnocholes-
terolernic, MDV-irtfected group had a significantiy higher
content of free and esterffed chdesterd, triacyl9lycerots,
and phosphdipids than did urUnfected controls.' Feed-
inq ttle infected animal a high-cholesterol dfet produced
a syrrergistic effect on Fipd accretion. Marek's disem
virus infection also caused an abnormal rise in cho-
4oesteryl ester (CE) synthesis with a concomitant reduc-
tion in CE hydrofysis in vi,ro, thus causing arterial lipid
accumulatton.° Infecaon of cells with herpesviruses in
vibv also produced profound effects on cellular eholes-
tzrroi membolism2° 22 which paralleled our in vivo data
Irtfection of avlan srrmooth musde cehs with MOV in vibe
greatly incteased the accumuladon of choiesterol and
CE20 This specific type of lipid accumulation, wf'tich atso
oceurs durinq the human arteriopashy, was due to de-
creased lysosomai and cytoplasmic CE hydrtalytie acov-
ities. Detailed anatysis of enzyme actWaDOn showed that
ttte CE cyc(e is aftered. nssufting in cytopiasmic CE ao-
cumulariort"-~ (Figure 2).
To defne some of the regulatory m®chanisms asso-
ciated with the contrat of the CE cycle, including cyto-
plasmic CE hydrolase, in herpesvirus-infected cells, the
level of CE hydrolase activation in MDV-infected cells
was examined in the presence of: 1) dibutyryl cyclic
adenosine monophosphate (AMP), 2) dibutyryl cyclic
AMP added together with protein kinase, or 3) agonists of
adenyiate cyclase.1 Activation of cytoplasmic CE hydro-
lase activity by cyclic AMP or protein kinase A was
blocked in MDV-+nfeaed cells but not in uninfected celis
or in cells infected with a control virus, turkey herpe.wirus
(WT) 2i Furttnrnlore the rate of cholesterof efflux from
arterial srmooth muscle cells challenged with dibutyryl cy-
clic AMP was unchanged in MDV-infetrted cells as cort}
pared with uninfected or HVT-infected ceils, in which ef-
flux was actuaiy incteased.202' Hence it has been pro-
posed that the reduced cytoplasmic CE hydroiase
(NCEH) activity in lipid-laden, ht:rpesvirus-+nfected celis
was due in part to the inability of the enzyme to be acti-
vated by the cyrlic AMP-protein Idnase A mechanism.2'
This may contribute to te patt+dogic changes seen in
MOV-infected arteriai cells, such as intracellular CE ao-
cunxtiatiotl.
We e)dended these studies to human arterial snlooth
muscle cells infected with herpes simplex virus (HSV)
type 1: HSV also induced accumulation of saturated tri-
acybycerois and CE in infected cells.22 The infected
cvUs had roductions in the CE hydrolytic activities and in
the enzyme itsetf, based on irtlmunopneciptrat+on data
(Figure 3) and ac6vity assays because of decreased
translaiion of the RNA that encodes the intracellular hy-
W
v
c+i
~
t~.t
~
-,,
W
cn
I
I
I
I
U
c_
I
I

Viral Patho9enesis of Atheroaclerosis 1199
yP Deeadr 1991, Vod 139. No. 6
I
I
I
I
I
I
I
I
Altered metabolic
events
Fi9ur. 2 Hnf+s ennapoxeaCan bva cdk
4adf~rg ro atre.ed mRaboL'c acraAty. T81r
sclxrna depfca a byporberic aequenue by
u6icb cvtulating berpc orracr nrars ceflr
6.vugli dx cav¢l wull m+d /wch to a(avsd
merabollc ac Mry, 7ba isarYS cvadasrsrg ubw
pnuams anekes b.v cauoV endodul;al uU
vy~m, wee ebesr aelkecm be deJecadwirb be
c:nsi Once dx s,t.ions me shed io cbe arrrsal
,vMcoat mrcV.L- ca14 bUo~btndtr{q ul1-0G
dsotertvyl es,cs (CF) rms mzs, .e.fib;a In
deveatd CE bydrolase ~~ (ACEf1 and
NYFFI). 7bis =m lead tb ino.aed CE a=w
vbn in OM e.d1 6s me forns of CEs.icb.ar
6jo1d rbvpkas uft* an a rbaacariuic fva.
~ o f~~
la~e~o cCe~ouc/am+t cdL Reg~>y+ud
droiases.?=' Because arachidonlc acid metabolitee such
as prostacyclin (PGl2) and 124-IETE atter CE hydrolysis in
arterial srrlooth musde cdts'. we rneesured these ei-
casaraids in HSV-infected edls. We obsxrAd a reduc-
tion in bolh spcnianeous t~basvline) and arachidanate-
induced reiease of the cycbnxypenase producX PGI2
and a Iipnxypenase product, 12-HEfE': Hence we be-
lieve that the herpesvirus-induced atherosckrosis re-
sults, in parr, from attefations in metaboiic control of CE
tmifficidng by eica~ in vasvJar cells. This concept
is depicted in Figure 4.
Role of Gytokines in Cholesterol Trafficking
in HSV-infected Cells
Recent studies have suggested that the immune system
may participate in aMerosclerosis. because monocyres
and T lymphocytes accumulate within the attlernsclerodc
lesion.=Yral infectlon could induce mediator release from
'vrQrune and hernatopoietic cells, which may be respon-
sibe for phenorypic changes in vascular cells. Of interest
in this regard are recertt studies that show tttiat herpesri-
ruses are capable of inducing messenger RNA expree-
I

1200 NzJjar
4tP D.rmnbir 1991, voL 139, Na 6
I
I
I
CTRL CTRL ' CELLS CELLS
(IgG) CELLS
Ad-2 ~ HSY
A 6 C
sion of marocyte-derived genes. For exarrtple, CMV in-
fecacn in vibc induces macrophages to increase the ax-
prestion of specific RNAs for intnrieLkin-1 0 (IL-1 P), tumor
necrasis factor (1T4F), and colorry stimulatinq factor43
The rde of TNF in the complex cytddne network in marn-
maJian cells is not fuy understood, particularty regarding
its andvirai ac&vity. Although TNF is an irxlucer of inter-
feron messenger RNA transcripts, a well-documented
cytoiane that has antiherpesviral activity, others have
shown that TiVF's antiviral aetiviy is rxot abolished in the
presence of anriserum to iraerferon," Wong and Go.d-
deto have postulated that the antiviral activity of TlVF is
attributab4e to lysis of viralty infected cells rather than to
inductiort of interferon. Other poscibie mechanisnns to ex-
plain the action of TNF irrvoh+e eitxosanaid metabdism,
since TNF's y6c effects can be partialy abdistxd with
cyck>exY9enase inhibaora Sudi studiea suggest that
0
Flqura 3. I e.f acid dbo-
kst*yl ata' bydolase.4CFlifrorn bnprs rmc*
~a3eca ~
XSY-infectenf (mai = 0.7) SMC cYhr.ro. Bio
synrbetic lat.JVrg of crll F.ot.ist uaas done
uRm f35~ (40 uCi PW 5 Y 10'
Mllrl. Farh lane mnv.ifkd aiaDtu I mg of of!
Praarn or a brnnogenan cwtslsrtng of 2 x
10e cells Gnnn.nobo6%t.e v.+re auhjeaed to
SDyPAGE and autorad/oRfapbY uwa pw
fari/1Cd laae A, a cofool, m+mwtoColatt
uas ohtained uub 8bc tcse of aormal rnosar
1RG. 7bis lovic siotta an arbarrm of .adtooc-
tiurry at M, 3S000 (arrour) (inolecu/ar
reigi4a #aoeft at:e, x 10 "d), ubitb apprar-
n.iarac ax molecutrr rscVbt of.tCES! Due to
t6e Imge qumuiry ofprotein lonGed on dxs
8atx aestenW of thr soviceval p.ot.ft ,tueb a
am (M, 43.0WA ndu1M msd purmcdlate
JUa>rvma (M, 5?,lXJO-65,000.~ ond nryonn
(1f. 200,000) pnripUared nonspecifttalty.
lat.e a. bnmunoprec~ouatssf matera! +iro-
taWfrwrs unrqf#=PA corraro! S+IGr wi.tg
muGACEff nwrsoclolfal MmLaiy. (mSC) .t
6tsfd [s abott" by dx asotu carreparult»g to
x, 55,000. lanu C, immursaprecipitared
ACFFIfrvm adcna sur inf.cned cef(s fDM1 ui-
rus aonrrol eroup.l larr D, rmmwioprcyo+-
aand m-ial case~OrYlb~ to M, 55,000
fitr+c MV Infiiaed SMGs u crnuidnablp ltss
imt tfrat fmtnd in Lmts B, l be lc.ls ef acsi+t
antd wryatbi a8aort in latt R(and (ane C)
K.+r b{q!a tlms ri5s trnotvsa atoun in laste
4 We aLso obsashd a prominsnt psotein
hmid yop.~iar9 at b!, 150.000 in lanr D
alty tr 6~6 mav Iz ojtx~P, w~m tspn. FI-
W11y, we assayed AtM1 aah.try eo.ff ia.cnun nuprtUPttatlon m axocbe espeimant ta
cDnfbrx that u.v ti+amsotoprecrpiixed ACEX
We fotaid tbai u'f could 6Mmfocpncfptrast
about 60% of dm .1Lgf in dx all bttud on
ow aaad,N,bw+d in ¢hr stpw,narasu mdpr/-
4Y Reprtnled unrrh panutvon,21
cytdvnes, such as TNF, can promote synthesis of ei-
cosanoid products that, in turn, can mediate specific bi-
ofogic etfacts such as modulation of cholesterd merab-
oiism, a concept originaly proposed by our laboratory.'b
8eaause HSV infectirn of vascular cells can produce
a biochemical and cytopattabgic effect virwaly indistin-
guishabie from atherosGerosis, we hypothesized that
tfsese cytokines can prevent CE accretion in arterial
srr*rth muscle cells that is associated wirh herpesvirus-
induced atheroscierrsis `d Turnor neorosis factor and IL-
1, but not interferon, prevented CE accumularion in H5v-
infected cells by induction of cyGic AMP-dependent CE
hydrolysis. Tlvs effect was medisted through the arachi-
donate 12-lipoxrygenase pattrway by 12-HETE, because
prrtrP.Btrnnt of aNis with a cocktail of lipoxygenase in-
hibitors abotist,ed Me an6virai effect and 12-HETE pro-
duction in the celi." 12-FiM is the rnajor lipoxygenase
f-
RVr
dx 1
oni,
met
ove
that
turn
hyd
tirn
kine
virus
Qaiiy
tT1et
caLL
lipic
ceU;
I
I
I
I
I
I
I
I
Pot ~
anc
AGr
atte
tt,ro
assi
I
itiea I
tein
broz
dicz
acsc
and
dt2t
I
byr
thro
ever

Viral Pathogenesis of Ath.roscl.rosis 1201
NP Desonesr 1991. VoL 139. Na 6
I
I
1.1
I
I
I
I
I
I
I
Fgurs 4. Kvpa sara iRj.aion blaeiespb'r+d
rrnrssduerion paebuavs in roeprioW onoot8
mu9cie cells 7hts modal sfiou4 6at bepcs tr
no [n(OWon ieads to deae+zedlvsaeomad by.
dro()k's f yF a. Fry ffie rtCflf ensVnu In a"-
rion, lxfeaion leadr ro deoeasnd easn.iesion
oj asartidonfc add X20.4,) to PGI, mnd 11-
F= tttiio6 in rtan a9t /tad ro a reductd
=knrron of adncylatr Cvclmr. Dwa.rzzrdc.v-
a!ir AMP prtxlutlion nuala in ds ull. Cws-
drruing br ebis alicrvid mem6olie a.grstrwe of
esmrs devxned ctietic &tfP nuf,.as lpss ac-
mnarrae ofpvrebt lrtnrsv 14 atius na,ducs.ig rbe
acruntiovt (rfsot.Rb pbopbo.Ylxxon) ol &e
cyropfatmic CZ Lry+dnolan (Nffll) to Oe aicriee
fo.m Jrom dx osnase fvm. 7laar meoatw/ic
nv+wr Ot obr cyaoplasm, muplaL to dsaw rn
dx+ hyaai-uK .aula bt r+uraeel/s<lm- CL ae.
ceria.i.
CF101
~C 4ACEN
FA
c2p:a
~ ~0,/
GH06+PA
I
P%.12FETE +7a~ , AGT
j M~s~ ~ I+Ca
qe1a. AMP na~
PA~
metabdite found in arterial smoottz muscle celis-'° This
overall conclusion is further supported by data that show
tetTNFand 1L-1 enhance 12-E-IETE productlon. which in
tum increases both intracellularcyclic AMP levels and CE
hydroiysis." Coilectivdy Uiese findings identified for the
first Ome a biochemical mechanism inwhved In a cyto-
tdr~induced reduction of lipid accumulation in herpes-
virus-infected ar[erial smooth muscle cells. This is pot&~
tially an important finding regarding control of chotesterol
metabolism during virai-induced atherosclerosis, be-
cause cytoldnes are importartt regulators of intreceliular
lipid metabolism, not only in arterial smooth muscle
ceHs,"g but also in monocyte-derived macrophages."
Potential Links Between Atherosclerosis
and Thrombosis
A link between the coagufation system, fibrinotysis, and
atherosclerosis has been proposed on the basis of
thrombotc processes atthe level of the endothefum. The
association between lesion progression, lipid abnom,al
ides invdving elevations of lipoproteins, including lipopro-
tein (a) [Lp(a)], and the fibrin depasition is now being
broadiy defired. Ear1y studes of Greenland Eakimos in-
dicated that their diet enriched in pofyunsaturated fatty
acids of fish oil origin, had an impact on p(ateiet function
and eicosanoid production. It has been hypothesized
that'rf the vessel wall is injured (or activated), for example,
by herpesviruses, the endottielium can become pro-
thrombotic, as evidenced by several cytopathologic
events. These include enhanced thrombin generation
and enhanced binding of platelets to endotheiium," de-
lJCEttWML
creased PG12 prvduction,`° enhanced tissue factor pro-
duction, reduced thrombornodulin expression" and an
inhibition of endothelial cell synthesis of heparan suifate
proteogiycan," which is closely related structurally to
heparin, a complex pofysaccharide that has anticoagu-
lant activity.
An example of molecular mimicry that relates throrn-
bfltic processes to atherogenic events invotv@s the re-
cent observadon of stnldng structurai homology benveen
the apoprotein (a) component of human Lp(a) and plas-
minogen,SO a major protein involved in fibrinoiysis.5' In-
creased levels of Lp(a) have been associated with atti-
enosclerasis in humans."L^-" Lipoprotein (a) as well as its
apo(a) also have been shown to compete with plasrnino-
gen for cellular binding sites,5t and Lp(a) has been as-
sociated with enhanced functional, antigenic, and trarr
script levels of plasminogen activator inhibitor (PAI) type
I by the endothdium.S' Piasminogen activator inhibitor
type 1 is the rapidiy acting physiologic inhibitor of both
tissue-type and urokinaselike plasminogen act'rvators.
The net effect of these events leads to down-fegulation of
plasmin generation at endothelial cell surface.' Lipopro-
tein (a) appears to function under some circumstances
as an inhibitor of plasminogen activators, by competing
vrith plasminogen for binding to streptokinase or by act-
ing as a competitive inhibitor of tissue piasminogen acti-
vator (t-PA) in the presence of fibnnogen. (KA Hajjar, per
sonal conmunication). Recendy we have observed that
HSV infection may interfere with normal endothelial ceu
flbrinoiysiss, as is the case with Lp(a), by inhibition of p41s-
minogen binding and increasing PAl-1 activity, thereby
preventing plasminogen activarion (unpublished obser-
va>ions). The mechanisms of action of HSV infection and

1202 Hajjar
4fPLtsvnls 7997, vot 239, No, 6
virat protein production on processes related to fibnndy
sis are currentty under investigation.
Viral Acfivafi'on of the Coagulation Cascade
An important event in the eary stages of atherosclerosis
is the adhesion of bbod cells to altered endothetium. Cer-
tainly both platelet (as well as neutrophil) and monocyte
adhesion to the endothelium are processes attributable
to the pathogenesis of thrombosis and atherosclerosis.
Monocytes can migrate into ttie vessel media and begin
accumuiating cholesterd, contributing to foam ceil for-
mat;on?
Herpes simplex virus-infected endothelium, as well as
endothelium exposed to TNF orto IL1, binds ptatelets,`6
granulocytas," and expresses tissue factor to a 9reater
extent than it does to noninfected cells.`° Herpes simplex
vinus-infected endothelium also expresses giyeoprvteins
encoded by the HSV genome.s' These partiapate in mo-
iecular mimicry because of their presumed furxaional role
on the erxiothelium. For example, gtyzoprotein E (gE)
can function as an Fc receptnr,55'5' and glycoprotein C
(QC) can atso serve as a complement (C3b) receptor.s "
A role for these proteins in the pathogenesis of endottie-
ual injury is suggested by the observation that poryrr>or-
phonuclear (PMN) celf adhesion to HSV-infected endot-
he5um can be blocked by antiviral serum S8
Central to the pathogenesis of vascular injury is the
localized activation of the coagulation cascade and the
adhesion of circulating inflammatory cells to the exposed
subendotheliaf vascular surface. Once adt*rent, tttiese
cells can secrete growth factors, proteolytic enzymes,
and cytoklnes that further activate the injured vessel sur
face.2-' For example, macrophage-derived cytokines
such as TNF and IL-t induce endothelial expression of
leukocyte adhesion molecules5° as well as tissue fac-
tor.60 These events promote further leukocyte accumula-
tion and locaJized tttrombin generation.
Recently we demonstrated thar infection of endothe-
lial cells prtxnotes enhanced monocyte adhssicn.c' En-
hanced adhesion was blocked by rnonockmat arrtibod
fes to the viraliy encoded ceil surface giycoprotein g(C)
but not by antibodies to g(D) or g(E). Adhesion nlsc was
blocked by treating endothelial cells with specific throm-
bin inhibitors or by growing ceus in prottirombin-depleted
serum. This suggested that thrombin plays a role in the
enhanced monocyte adhesion. Glycoprotein C bound
and promoted activation of factor X on infected endothe-
fal cells, thereby contributing to thrombin generation. To
further support the hypothesis that g(C) was indeed irr
volved in rnonocyte adhesion and factor X binding, we
used cells (L cells) that do not normally express this gy
coprotein but could be transfected with the gene for
herpes-virus gtycoprotein C.6' We found ttiai factor X
bound to transfected L cells thatwere induced to express
g(C) by dezamethasone, a steroid horrnone that acti-
vated the MMTV-LTR promoter region of an artificiat g(C)
gene construct. Cross-linking and irnmunopreeipitation
studies dernonstrated factor X-g(C) complex formation
on the cell surface, suggesting that g(C}dependent
thrombin generation by herpes-infected endothelium
may be an important mediator of vascular pathology dur-
ing viral infection. Thrombin itsstf can elicit a variety of
cellular events. These include monocyte and neutrophil
aGhesion, and cytokine refease and platelet activation on
a damaged surface."-'61 Each one of these cytopatho
logic effects has been iinked to ft role of inflarnmaiion as
it may present itself during the pathogenesis of athero-
scterosis.
Identificaf+on of a Monocyte Receptor on
Herpesviral-infected Endob~elium
Endottretial cells express several leukocyte receptors. in-
duding GMP-140 (also known as PADGEM or CD 6Z),
ELAM-1,ICAM-1 and 2, and VCAM-1 on their surfaces in
response to cyrokine or exposure to other agonists.02
NorrnaltyGMP 140 is acytoptasmic protein found in rest-
ing endothelial ceits found on the membrane of Weibel
Palade bodies ° After stimulation by thrombin, histamine
or complement proteins. the Welbel-Pafade body is rap-
idly franslocated, and its membrane becomes incorpo-
rated into the plasma membrane, resulting in surface ez-
pression of GMP 140.°0 This mechanism of new protein
expression, ie, translocation from a preformed intracellu-
lar membrane compartment to the cell surface, does not
require de novo protein syrrttsP_sis. As described in the
previous section, our recent data support tiie following
model: HSV infection induces endothetial cell surface ex-
pression of HSV g(C), which acts as a binding site for
factor X. Concomitant generation of tissue factor converts
bound factor X to an active prothrombinase, leading to
generation of thrombin in tf* microenvironmerrt of the
infection 6i Recenty we have exaended this hypothesis,
because we now have evidence that thrombin can act in
an autocrine manner to induce expression of the leuko-
cyte receptor GMP1a0.a6' Our data indicate tftat mono-
cyte adhesion induced by HSV infect;on is blocked by
anti-GMP140. but not by anti-ELAM or antibodies to other
adhesion molecules. This suggests that GMP-140 is a
major receptor for monocytes on the HSV-infected endo-
tltielium." These findings are summarized in Figure 5,
which shows that HSV=utfected endotheiiat cells generate
thrombin, which predisposes to increased rnonoc.yte ad-
herence by ezpressing the monocyte receptor GMP-1a0.
Thrombin generation by these cells is dependent on the
91
eXprf
X bin
As st,
in ft
(LFA
ICAN
cetis,'
viralty
spec
Simii~
to stir
syste
bodiE
I
I
I
I
I
I
I
I
I
1
TF
HSV-;
throrr
weil i
can n ~
platel
tivatec
may c
injury,
of ree
ucts.`
infecu
endot
Mc
sites ii
af fact,
in9 to
lappir
gions
~
I
I

Virat Pathogenesis of Ath.rosclerosis 1203
.VP Dasnlxr 1.9,91. VoL )-0, JJO, 6
I
I
I
I
I
I
I
I
I
I
I
I
I
...::::::....
HSV-infected EC
SMC
Fpun S. VbW aR reuwn of mr magulatlon ea=dr, HypodNffea! WttittW depiarng bau beprcs snPkr ivus
fNSIV) ny4ztion G= lead m a
p.or6rombon4 psarfi~rlwoeic ~rr o.r d*e,fdodwGar.a&faor by tnduang ihr ryr,mLes mid cpsaion
o18lyKqoouv, (C) uticb ran
ac+zr ar a 6indbig arrs)o Faacr X a key pmvnrmr of du encRularqn aataaxtr. 7bir tnoatfod
birlQin,q ojFactor X and fa ruhseqirnt
co>wasron jo dx aalxelvnS Facor \a, uar rtad ro dx aonarao3 ofpo&rowbvs to &onbrn rT,oao. l!a). Wben
Facxor r1a it g-e.aed,
d* = b+dtiaenwface eT.ezio.r of a nio+aocyrc mcep(or fGMP14U ut~ frt non omfsomorr motacsYr
ardbenorl ro dx andorb=m and
+,uiu=~ af an isyrammeao.r atVo.iae by aaimrtns dw qyaoi- rirnevt Eace of d),,u cy,opzcorogrc fea-
rm, psdipose ro a6ero-
seL+osa ared dsombwiC
expression of HSV g(C), which can act as a site for factor
X binding and asscmblyoftfie protttrombinase complex
as stated earlier, other receptors do not play a major role
in this celt system. For ezample, the leukocyte integrirs
(LFA-1. Mac-1, and p15o,95) mediate adhesion to
ICAM-1 and iCAM-2 on cytokirtcstirnulated endotheliel
cells,65 but do not appear to play a rore in adhesion to the
virally infected celts, based on lack of inhibition seen with
specific monocional antibodies or RGDS peptides.s`
Simitarty VCAM-1, which mediates fympftocyte adhssion
to stimulated endothelial cells,e6 is not functionai in this
system, based on ladc of inhibbort with anti-VCAM anti-
bodies."
The significance of a procoagulant phenotype of
HSV-infected cells is considerable: IocBi generation of
thrombin at the site of infectdon may actt`rate platelets as
weil as endothefial cells. Thcarnbin-stimulated platolets
can adhere to monocytes, and ttterefore can recruit more
platelets into ttv site of injury ?,6`-6' The presence of ao-
tivated platelets and monocytes at the tocvs of infecrion
ruy contribute further to the deYeiopmertt of vascular
;njury, chronic inflammation, and atherosckrosis by way
of release of cytokines and lipoxygenase prod-
ucts.","6` Expression of adhesion motecules on HSV-
infected cells thus may be an initiai step in v'rca}-rrxdiabsd
endotheliaW injury and atherogen¢siz.
Most recentiy, to identify the putative celMnteractlng
sites in factor X, we have analyzed the stnucturat domains
of factor X that are involved in the coordination of its bind-
irsg to membrane receptors.6t A group of partially over-
lapping synthetic peptides repre,sentatn+e of different re-
gions of the factorX molemb Nwre used, Two unrelated
surface membrane receptor regions that ceordinate this
neaoqnition have been identified: CD11 bCD18 on mono-
cytes and plycoprotein C(gC) on HSV-infected endothe-
I'axn, ie, they recognize a comrnon strucaual motif in the
catalytic domain of factor X.°° Each of the peptides we
used blocked factot Xa-mediated monocyte procaagu
lant activity and suppressed monocyte adhesion, The
stn.ctue of the catalytic domatn of factor X centaining the
tfuee sites that are invofved in binding to herpesvirai g(C)
and CD11 b/C018 was modelcd carnputationally. Factor
X associates itself with herpesvirus-infected endoUheliaJ
cell and monocyte rectptors using a similar mofecular
reoognition motif. We were able to show that the vascular
cell binding region of factor X is organ'ized into three dis-
tinct interacting sites. The peptidyl anabgs prevent the
consequences of vascular generation of tt,rombin such
as PMN adhesion to endotheaial colls, chernotaxis, and
monocyte-mediated deposition of insoluble 6brin. Our
understanding of the cO biology of this system coupled
with the molecuiar modeiing offers an unprecedented
paradigm of the molecular compledty of this thrombotic
process that can be linked to vira}-induced atherosclero-
sis; it also directiy links the actinration of caagutariort pro-
tens on vascular cells to typical irtAammato"rorrtbotic
reactions. This was observed by corutituting three spa-
tially distant surface Ioops that define a unique three-
ddmensional celt-interacting network in the ligand, as
shoNm in Figure 6.
In summary, we observed that speciflc synthedc pep-
tides inhibit facter X binding to maiocyrte CD11 b/CD18
and to g(C) expressed on herpesvirus-irdecteld endotfi-e
iial cells. These peptides blocked rnonocyte generation
I

1204 Hajjar
AJP Dftv"rlas 1997, LbL 139. +No. 6
Fipure 6. Sss.a+sd n~orL! of dz Faaor x eardyKic do>+~ llomwlogy modd bLi4Gng tcdinlqua uwe usad ro
eo.lsnT.ca a ntoder oJr6r
crualyetr do.nairr oJJaaa-X frons a oyaal snArnor of aypcmogerz Snt.asirr[ly ebns&std re,qfont uWs
vl.nrifstYt by etara! !n¢~e~.ziors of
dhe=.ar-res of v3Ps>y; cGynroVyprr>R ekaroaie arrd ht1lbttnn, and rbr Faua' x myunrar uw aligrrard
muraralh, uIrb dx sn7t+c.rcr of dw.e
pomacec Avomc coa>dtNares fo. haaFbo.rr and eo,um,rdside drairu of fcaro X awr amgsrrd daealy
frri.n aVvcinoRen for dwe m~rwallv
asuezie+d rMiom Gnordmata of noaroomxard arde dalnt uutn'rt sa r.cirsalty mnsmud rrgior~ ~ Od jor
mininra= oe wlcrp ~ctib
o~ osona Ato"ele aaadinaorr fEr ,~src7rsall,y c~scblr (loap) *Cgto.+s a~ere ra4en Jrvm a p.io..
~rLdxd nec~dr.[ of Fvao. Xa rT.
EaiqvsETOrs Lx a1.) 7be Eninal nsodrl sat.aure aar eneV mtnvniud tn sc{qaa fvst aUuuing all srde
cf+alrzs to m-lca, w&d rben re(mnnq all
IIde tl~evns togedxr uab rlar baek6unr atonrs of d t foop repsoru Baekhortt ef Facsur X uucihric
dnmatm (rib8on rLicgrm++,d CaraA-r/c rnad
btwr e.an ddr Wml mofaoe rcmuerj [r.yo p~ 1(G}DMFn) (67) r_PKlsofaeo (RYfuy Larip peprfde
3(IDRStDURG) (67), U'K riofau /eft
cdcp peprlde 9 2YpnARr7w) (67J, ePIC sofao. (rop) exardus rlsk ro Ilkrsr dxiva v+liow cPK (rou,ir
orr+ar) rhr Nrn+.,isucs oJm. u4ui!}*c
rfornain fs ltrwrd jur a6oco pepr/de 1, r6e o~bmwr bi+uiistg grmt r it apprpsi+nauly twrical and (o
rbr nbht af dW. o-tarl and rbr Gu+mbuc:
R ~(~~Id'L~ rderec oj Faaar x a,~rr.+~tes for mbic6 no sawsovJ enfor+rrarson ic atailable) c~ dr
Garrrminta of~iri~L: 2.
of thrombin and prevented monocyte adhesion to HSI-
infected endokhelium, It is possib(etriai selective interrup-
tion of coagulation by such symthetic analogs may impact
positively to reduce vascular injury associated with
morrocyte adhwrence and HSV infection of ehe endottie-
(ium.
Molecular Genetics of Atherosclerosis
The monaclonal hypothesis of Benditt and Benditt` was
based on the observation that 75% of ath.rosderotic
plaques from human tissues removed at surgery or at
autopsy derrronstrated a monocb)al pherotype of the
gtucose-6 phosphate dehydrogenase (G-6-PD) enZyme,
based on etecirophoretlc rrobiUty. This technique too+c
advantage of the fact that the poiyrnorphic Eortns of this
enzyme are expressed in an Xainked fashion. MediaJ
cells from regions adjacent to atherosc{erotSc plaques
frorn nonpiaque areas display equal arnounts of each
pofymorphic form of the enzyme, as would be expected
in an X-iinked gene, because one of the two X chromo-
somes is inacvvated early in embryonic development,
Smilar resuhs have been obtained by other laborato-
ries °°'70 however the interpretation of these experiments
in supporting the monoclonal hypothesis has been chai-
lenged." The principal argument is that the G-frPD
marker may be linked to sonle other gene that gives
ttuse cells a selective growth advantage, ie, a'pheno-
type-sefective advantage' wittw the proliferative lesion
being trufy rna*ocfonel in origin.
Tfw monoclonal hypottiesis purports that the srnooth
muscle cell prel'rferacion seen in the ari,ernsclerotic lesion
is similar to a benign tumor, for example, a uterine leio-
n
inft
no I
I
in
hu'
rat '
_
(r1C -
the
nOr .
D
h ~
-
nar
Ma
3T; ,
forr
re6
has
pla
I
~
7, t:
BLUt
pla
aic
sior
enc
cer
trar
plac
labc
rYpE
rec(
with
anti
ang
latc
Thes
gen
anc
cise
unic
f
Iden
rece
I
I
I
I
I
I
,
tervi
mlh
cedl:
Cora
taRz
forrr
I
I
